284 related articles for article (PubMed ID: 22082309)
1. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
Mazurek AM; Olbryt M
Neoplasma; 2012; 59(1):43-51. PubMed ID: 22082309
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K
Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
[TBL] [Abstract][Full Text] [Related]
6. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
Pan Q; Chanthery Y; Liang WC; Stawicki S; Mak J; Rathore N; Tong RK; Kowalski J; Yee SF; Pacheco G; Ross S; Cheng Z; Le Couter J; Plowman G; Peale F; Koch AW; Wu Y; Bagri A; Tessier-Lavigne M; Watts RJ
Cancer Cell; 2007 Jan; 11(1):53-67. PubMed ID: 17222790
[TBL] [Abstract][Full Text] [Related]
7. Autocrine semaphorin 3A signaling promotes glioblastoma dispersal.
Bagci T; Wu JK; Pfannl R; Ilag LL; Jay DG
Oncogene; 2009 Oct; 28(40):3537-50. PubMed ID: 19684614
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of neuropilin-1 and its receptors, VEGF/Semaphorin 3a, in normal and cancer cells.
Haixia D; Jingsong Z; Lei J; Hairong D; Jun W; Hang X; Weixian C
Cell Biochem Biophys; 2011 Jan; 59(1):39-47. PubMed ID: 20711684
[TBL] [Abstract][Full Text] [Related]
9. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.
Casazza A; Laoui D; Wenes M; Rizzolio S; Bassani N; Mambretti M; Deschoemaeker S; Van Ginderachter JA; Tamagnone L; Mazzone M
Cancer Cell; 2013 Dec; 24(6):695-709. PubMed ID: 24332039
[TBL] [Abstract][Full Text] [Related]
10. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.
Liang WC; Dennis MS; Stawicki S; Chanthery Y; Pan Q; Chen Y; Eigenbrot C; Yin J; Koch AW; Wu X; Ferrara N; Bagri A; Tessier-Lavigne M; Watts RJ; Wu Y
J Mol Biol; 2007 Feb; 366(3):815-29. PubMed ID: 17196977
[TBL] [Abstract][Full Text] [Related]
11. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins.
Rieger J; Wick W; Weller M
Glia; 2003 Jun; 42(4):379-89. PubMed ID: 12730958
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of axonal outgrowth in the tumor environment: involvement of class 3 semaphorins.
Vachkov IH; Huang X; Yamada Y; Tonchev AB; Yamashima T; Kato S; Takakura N
Cancer Sci; 2007 Aug; 98(8):1192-7. PubMed ID: 17498201
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin-3A and its receptor neuropilin-1 are predominantly expressed in endothelial cells along the rostral migratory stream of young and adult mice.
Meléndez-Herrera E; Colín-Castelán D; Varela-Echavarría A; Gutiérrez-Ospina G
Cell Tissue Res; 2008 Aug; 333(2):175-84. PubMed ID: 18574596
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin signaling facilitates cleft formation in the developing salivary gland.
Chung L; Yang TL; Huang HR; Hsu SM; Cheng HJ; Huang PH
Development; 2007 Aug; 134(16):2935-45. PubMed ID: 17626059
[TBL] [Abstract][Full Text] [Related]
15. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells.
Bachelder RE; Lipscomb EA; Lin X; Wendt MA; Chadborn NH; Eickholt BJ; Mercurio AM
Cancer Res; 2003 Sep; 63(17):5230-3. PubMed ID: 14500350
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin 1: function and therapeutic potential in cancer.
Chaudhary B; Khaled YS; Ammori BJ; Elkord E
Cancer Immunol Immunother; 2014 Feb; 63(2):81-99. PubMed ID: 24263240
[TBL] [Abstract][Full Text] [Related]
17. Selective requirements for NRP1 ligands during neurovascular patterning.
Vieira JM; Schwarz Q; Ruhrberg C
Development; 2007 May; 134(10):1833-43. PubMed ID: 17428830
[TBL] [Abstract][Full Text] [Related]
18. Motoneuronal Sema3C is essential for setting stereotyped motor tract positioning in limb-derived chemotropic semaphorins.
Sanyas I; Bozon M; Moret F; Castellani V
Development; 2012 Oct; 139(19):3633-43. PubMed ID: 22899844
[TBL] [Abstract][Full Text] [Related]
19. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
[TBL] [Abstract][Full Text] [Related]
20. Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration.
Kurschat P; Bielenberg D; Rossignol-Tallandier M; Stahl A; Klagsbrun M
J Biol Chem; 2006 Feb; 281(5):2721-9. PubMed ID: 16330548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
